News out of the major U.S. medical device hub of Minnesota raises more questions about whether the funding slump has really ended.
Fewer Minnesota medtech companies are raising money, and they’ve been commanding a smaller share of the life science funding pie of late, according to LifeScience Alley, a trade group of medical device and pharmaceutical firms.
The medtech sector raised only 67% of total Minnesota life science funding during the third quarter of 2014, down from 95% for the same period a year ago.
Help employers find you! Check out all the jobs and post your resume.
